Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
Asian Journal of Pharmaceutical Sciences
ISSN 1818-0876 · eISSN 2221-285X · Shenyang Pharmaceutical University · China
Asian Journal of Pharmaceutical Sciences: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 12.56; diamond open access (no APC); no APC; median 156 days to acceptance (94 articles, last 24 months); 54 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Asian Journal of Pharmaceutical Sciences is published by Shenyang Pharmaceutical University and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Drug Solubulity and Delivery Systems, Nanoparticle-Based Drug Delivery and Advanced Drug Delivery Systems, together about 36.5% of its articles. Its main subfields are Pharmaceutical Science and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Peer Review under responsibility of Shenyang Pharmaceutical University. Asian Journal of Pharmaceutical Sciences (AJPS) is the official journal of Asian Federation for Pharmaceutical Sciences (AFPS) and is indexed by Science Citation Index Expanded (SCIE). It provides the forum for reporting innovations, production methods, technologies, initiatives and the application of scientific knowledge to all aspects of pharmaceutics, including controlled drug release systems, drug targeting, physical pharmacy, pharmacodynamics, pharmacokinetics, pharmacogenomics, biopharmaceutics, drug and prodrug design, pharmaceutical analysis, drug stability, quality control, pharmaceutical engineering and material sciences. Editorial Board
From the journal's Aims & Scope
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
Editor-in-chief Tsuneji NagaiPublisher website
Editorial board by country: 45 in mainland China (about 46%); most named Mainland China 45, South Korea 13, Japan 12, United States 7, Thailand 4 (97 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics12.3%
- Nanoparticle-Based Drug DeliveryMaterials Science12.2%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics12.1%
- Nanoplatforms for cancer theranosticsEngineering9.9%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology7.5%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics5.9%
- Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology3.4%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 12.56LetPub ·
- Impact factor (publisher)
- 12.6Publisher website ·
- CiteScore 2026-06
- 20.5LetPub ·
- CiteScore (publisher)
- 20.5Publisher website ·
- SJR 2026-06
- 2.2LetPub ·
- SNIP 2026-06
- 1.68LetPub ·
- h-index
- 27LetPub ·
- h-index
- 91OpenAlex ·
- i10-index
- 618OpenAlex ·
- 2-year mean citedness
- 7.47OpenAlex ·
- Self-citation rate
- 1.6%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 67LetPub ·
Articles by year OpenAlex count · 1,001 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 50 | 18 |
| 2025 | 54 | 54 | 321 |
| 2024 | 70 | 70 | 960 |
| 2023 | 60 | 60 | 1,827 |
| 2022 | 54 | 54 | 2,281 |
| 2021 | 46 | 46 | 2,126 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
156 daysMedian, submission to acceptance · P25–P75 110 days – 205 days
- Acceptance to online
- median 43 days (94 articles)
- Submission to online
- median 204 days
- Sample
- 94 articles with submission and acceptance dates (124 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 17 weeksLetPub ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 0 | — | — | |
| LetPub | No APC | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 200 words
- Keywords
- ≥ 6
- Suggested reviewers
- Optional
- Highlights
- Required
- Cover letter
- Required
Article types accepted7
- original research paperContributions falling into the following categories will be considered for publication: original research papers, reviews, short communications, perspective and…Length not stated
- perspectiveContributions falling into the following categories will be considered for publication: original research papers, reviews, short communications, perspective and…Length not stated
- perspective&commentsPerspective&Comments max word 2000, max 1 figure and max 6 references. No abstract, keywords and table. Have to be controlled in 3 pages after productionLength not stated
- research articleResearch article max word 6,000Length not stated
- reviewContributions falling into the following categories will be considered for publication: original research papers, reviews, short communications, perspective and…Length not stated
- review articleReview article max word 10,000Length not stated
- short communicationContributions falling into the following categories will be considered for publication: original research papers, reviews, short communications, perspective and…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Plagiarism, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper. Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use. Authors preparing a manuscript for this journal may use AI to…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: The conception and design of the study, or acquisition of data, or analysis and interpretation of dataDrafting the article or revising it critically for important intellectual content.Final approval of the version to be submitted. All authors are accountable for all aspects of the work, to ensure that questions related…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include: EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board…
Source ↗Publisher website ·- License & copyright Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
Allows users to: distribute and copy the article; and include in a collective work (such as an anthology). These uses are permitted only for non-commercial purposes, and provided the user: gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); provides a link to the license; and does not alter or modify the article. If you need to comply with yo…
Source ↗Publisher website ·- Open access KeAi Guide for authors: Open Access
ORCiD ID supported Model summary
This is an open access journal: all articles will be immediately and permanently free for everyone to read and download. To provide open access, this journal has an open access fee (also known as an article publishing charge APC) which needs to be paid by the authors or on their behalf e.g. by their research funder or institution. Permitted third party (re)use is defined by the following Creative …
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors to determine suitability for publication in this journal. If your submission is deemed suitable, it will typically be sent to a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected will…
Source ↗Publisher website ·- Plagiarism
Plagiarism screening with iThenticate CrossCheck Model summary
Submissions to KeAi journals are automatically screened using iThenticate's CrossCheck within the editorial system to detect plagiarism issues including instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Preprints Preprint sharing
Preprint sharing allowed Model summary
Authors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication. We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Shenyang Pharmaceutical University
- Country or region
- China
- Language
- English
- ISSN
- 1818-0876
- Electronic ISSN
- 2221-285X
- Society / sponsor
- Asian Federation for Pharmaceutical Sciences
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Asian Journal of Pharmaceutical Sciences
What CAS zone is Asian Journal of Pharmaceutical Sciences in?
In the 2025 upgraded edition of the CAS Journal Ranking, Asian Journal of Pharmaceutical Sciences is in Zone 1 of Medicine, and in Zone 1 of the minor category Pharmacology & Pharmacy; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Asian Journal of Pharmaceutical Sciences?
The latest impact factor listed by LetPub is 12.56; CiteScore 20.5, h-index 91.
How long does peer review take at Asian Journal of Pharmaceutical Sciences?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 156 days (interquartile range 110–205 days); authors report an average review time of about 17 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Asian Journal of Pharmaceutical Sciences?
According to the journal's author guidelines: Abstract: ≤ 200 words; Keywords: ≥ 6; Suggested reviewers: Optional; Highlights: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Asian Journal of Pharmaceutical Sciences based?
Of the 97 board members whose country the journal's board page names, 45 (about 46%) are in mainland China; the countries named most often are Mainland China (45), South Korea (13) and Japan (12). Counted from the institutions listed on the board page; for reference only.
Which databases index Asian Journal of Pharmaceutical Sciences?
According to LetPub and DOAJ records, Asian Journal of Pharmaceutical Sciences is indexed in SCIE, Scopus and DOAJ.
Is Asian Journal of Pharmaceutical Sciences open access, and what is the APC?
Asian Journal of Pharmaceutical Sciences is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .